Press release today regarding Tovaxin. We've all been dosed! All 150 of us! Yeah!!!
Quote:
David McWilliams, president and chief executive officer of Opexa Therapeutics, stated, "I am pleased by the steady progress of the trial and the recommendation of the DSMB. We have delivered all Tovaxin doses to patients in the study and now look forward to presenting 52-week topline results of the TERMS Phase IIb study in September. McWilliams continued, “with this report, we are aggressively moving forward with our regulatory plans and furthering our discussion with potential strategic development partners."
|
http://www.businesswire.com/portal/s...ewID=news_view
There is a lot more information in the article about the progress of the trial, the analyses and the process, so please read the article!